The median age of patients diagnosed with advanced non-small-cell lung cancer (NSCLC) has steadily increased over the recent years and is presently 70 years. Despite this, the elderly are significantly underrepresented in clinical trials…
Evidence-Based Treatment Can Be Improved By Greater Representation Of Elderly Patients In Phase III Trials
by admin | Mar 3, 2013 | Senior health